Therefore the acute change in BDNF levels and TrkB signaling in our study, equivalent to the BDNF loss that occurs in human AD patients (Tapia-Arancibia et al., 2008), could have induced increased Aβ production; however, we did not observe this. The gene discussed is NTRK2; the disease is Alzheimer disease.